Skip to main content
Erschienen in: Supportive Care in Cancer 10/2014

01.10.2014 | Original Article

Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid

verfasst von: Fernanda Gonçalves. Basso, Ana Paula Silveira. Turrioni, Diana Gabiela Soares, Vanderlei Salvador Bagnato, Josimeri Hebling, Carlos Alberto de Souza Costa

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Clinical studies have shown that low-level laser therapy (LLLT) can improve local tissue healing of bisphosphonate-induced osteonecrosis of the jaw. However, the effects of laser irradiation on bisphosphonate-treated osteoblasts have not been completely elucidated.

Methods

Human osteoblasts were cultured in plain culture medium (DMEM). After 48 h, plain DMEM was replaced by DMEM with no fetal bovine serum, for a 24-h incubation followed by addition of zoledronic acid (5 μM) for additional 48 h. Cells were subjected to LLLT (InGaAsP; 780 ± 3 nm; 0.025 W) at 0.5, 1.5, 3, 5, and 7 J/cm2, three times every 24 h. Cell viability, total protein production, alkaline phosphatase activity (ALP), mineral nodule formation, gene expression of collagen type I and ALP, and cell morphology were evaluated.

Results

LLLT at 0.5 J/cm2 increased cell viability of cultured osteoblasts. ALP activity and gene expression, in addition to mineral nodule formation and Col-I gene expression, were not increased by LLLT. LLLT applied to ZA-treated cells increased Col-I expression at 0.5, 1.5, and 3 J/cm2 but did not improve any other cell activity assessed.

Conclusion

LLLT showed limited effects on bisphosphonate-treated osteoblasts.
Literatur
1.
Zurück zum Zitat Migliorati CA, Woo S, Hewson I, Barasch A, Elting L, Spjikervet FKL, Brennan MT (2009) A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer 18:1099–1106. doi:10.2174/157488709788185978 CrossRef Migliorati CA, Woo S, Hewson I, Barasch A, Elting L, Spjikervet FKL, Brennan MT (2009) A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer 18:1099–1106. doi:10.​2174/​1574887097881859​78 CrossRef
3.
Zurück zum Zitat Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo S (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis. J Am Dent Assoc 136:1658–1668PubMedCrossRef Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo S (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis. J Am Dent Assoc 136:1658–1668PubMedCrossRef
4.
Zurück zum Zitat Otto S, Pautke C, Opelz C, Westphal I, Drosse I, Schwager J, Bauss F, Ehrenfeld M, Scheker M (2010) Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg 68:2837–2845PubMedCrossRef Otto S, Pautke C, Opelz C, Westphal I, Drosse I, Schwager J, Bauss F, Ehrenfeld M, Scheker M (2010) Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg 68:2837–2845PubMedCrossRef
6.
Zurück zum Zitat Scheper MA, Badros A, Salama AR, Warburton G, Cullen KJ, Weikel DS, Meiller TF (2009) A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer 17:1553–1557. doi:10.1007/s00520-009-0710-7 PubMedCrossRef Scheper MA, Badros A, Salama AR, Warburton G, Cullen KJ, Weikel DS, Meiller TF (2009) A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer 17:1553–1557. doi:10.​1007/​s00520-009-0710-7 PubMedCrossRef
10.
Zurück zum Zitat Scoletta M, Arduino PG, Reggio L, Dalmasso P, Mozatti M (2010) Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study. Photomed Laser Surg 28:179–184. doi:10.1089/pho.2009.2501 PubMedCrossRef Scoletta M, Arduino PG, Reggio L, Dalmasso P, Mozatti M (2010) Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study. Photomed Laser Surg 28:179–184. doi:10.​1089/​pho.​2009.​2501 PubMedCrossRef
11.
Zurück zum Zitat Romeo U, Galanakis A, Marias C, Del Vecchio A, Tenore G, Palaia G, Vescove I, Polimeni A (2011) Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg 29:447–452. doi:10.1089/pho.2010.2835 PubMedCrossRef Romeo U, Galanakis A, Marias C, Del Vecchio A, Tenore G, Palaia G, Vescove I, Polimeni A (2011) Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg 29:447–452. doi:10.​1089/​pho.​2010.​2835 PubMedCrossRef
12.
Zurück zum Zitat Vescovi P, Manfredi M, Merigo E, Guidotti R, Meleti M, Pedrazzi G, Fornaini C, Bonanini M, Ferri T, Nammour S (2012) Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg 30:5–13. doi:10.1089/pho.2010.2955 PubMedCrossRef Vescovi P, Manfredi M, Merigo E, Guidotti R, Meleti M, Pedrazzi G, Fornaini C, Bonanini M, Ferri T, Nammour S (2012) Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg 30:5–13. doi:10.​1089/​pho.​2010.​2955 PubMedCrossRef
14.
16.
17.
18.
Zurück zum Zitat Basso FG, Pansani TN, Turrioni APS, Kurachi C, Bagnato VS, Hebling J, de Souza Costa CA (2013) Biostimulatory effects of low-level laser therapy on epithelial cells and gingival fibroblasts treated with zoledronic acid. Laser Phys 23 (Epub ahead of print). doi: 10.1088/1054-660X/23/5/055601 Basso FG, Pansani TN, Turrioni APS, Kurachi C, Bagnato VS, Hebling J, de Souza Costa CA (2013) Biostimulatory effects of low-level laser therapy on epithelial cells and gingival fibroblasts treated with zoledronic acid. Laser Phys 23 (Epub ahead of print). doi: 10.​1088/​1054-660X/​23/​5/​055601
19.
Zurück zum Zitat Noqueira GT, Mesquita-Ferrari RA, Souza NHC, Artilheiro PP, Albertini R, Bussadori SK, Fernandes KPS (2012) Effect of low-level laser therapy on proliferation, differentiation, and adhesion of steroid-treated osteoblasts. Lasers Med Sci 27:1189–1193. doi:10.1007/s10103-011-1035-6 CrossRef Noqueira GT, Mesquita-Ferrari RA, Souza NHC, Artilheiro PP, Albertini R, Bussadori SK, Fernandes KPS (2012) Effect of low-level laser therapy on proliferation, differentiation, and adhesion of steroid-treated osteoblasts. Lasers Med Sci 27:1189–1193. doi:10.​1007/​s10103-011-1035-6 CrossRef
20.
Zurück zum Zitat Schwartz-Filho HO, Reimer AC, Marcantonio C, Marcantonio E Jr, Marcantonio RA (2011) Effects of low-level laser therapy (685nm) at different doses in osteogenic cell cultures. Lasers Med Sci 26:539–543. doi:10.1007/s10103-011-0902-5 PubMedCrossRef Schwartz-Filho HO, Reimer AC, Marcantonio C, Marcantonio E Jr, Marcantonio RA (2011) Effects of low-level laser therapy (685nm) at different doses in osteogenic cell cultures. Lasers Med Sci 26:539–543. doi:10.​1007/​s10103-011-0902-5 PubMedCrossRef
25.
Zurück zum Zitat Fujihara NA, Hiraki KRN, Marques MM (2006) Irradiation at 780 nm increases proliferation rate of osteoblasts independently of dexamethasone presence. Lasers Surg Med 38:332–336. doi:10.1002/lsm.20298 PubMedCrossRef Fujihara NA, Hiraki KRN, Marques MM (2006) Irradiation at 780 nm increases proliferation rate of osteoblasts independently of dexamethasone presence. Lasers Surg Med 38:332–336. doi:10.​1002/​lsm.​20298 PubMedCrossRef
26.
Zurück zum Zitat Haxsen V, Schikora D, Sommer U, Remppis A, Greten J, Kasperk C (2008) Relevance of laser irradiance threshold in the induction of alkaline phosphatase in human osteoblast cultures. Lasers Med Sci 23:381–384. doi:10.1007/s10103-007-0511-5 PubMedCrossRef Haxsen V, Schikora D, Sommer U, Remppis A, Greten J, Kasperk C (2008) Relevance of laser irradiance threshold in the induction of alkaline phosphatase in human osteoblast cultures. Lasers Med Sci 23:381–384. doi:10.​1007/​s10103-007-0511-5 PubMedCrossRef
27.
Zurück zum Zitat Tagliani MM, Oliveira CF, Lins EC, Kurachi C, Hebling J, Bagnato VS, de Souza Costa CA (2010) Nutritional stress enhances cell viability of odontoblastlike cells subjected to low level laser irradiation. Laser Phys Lett 7:247–251. doi:10.1002/lapl.200910137 CrossRef Tagliani MM, Oliveira CF, Lins EC, Kurachi C, Hebling J, Bagnato VS, de Souza Costa CA (2010) Nutritional stress enhances cell viability of odontoblastlike cells subjected to low level laser irradiation. Laser Phys Lett 7:247–251. doi:10.​1002/​lapl.​200910137 CrossRef
28.
Zurück zum Zitat Trindade FZ, Ribeiro APD, Sacono NT, Oliveira CF, Lessa FCR, Hebling J, Costa CAS (2009) Trans-enamel and trans-dentinal cytotoxic effects of 35% H2O2 bleaching gel on cultured odontoblast cell lines after consecutive applications. Int Endod J 42:516–524. doi:10.1111/j.1365-2591.2009.01544.x PubMedCrossRef Trindade FZ, Ribeiro APD, Sacono NT, Oliveira CF, Lessa FCR, Hebling J, Costa CAS (2009) Trans-enamel and trans-dentinal cytotoxic effects of 35% H2O2 bleaching gel on cultured odontoblast cell lines after consecutive applications. Int Endod J 42:516–524. doi:10.​1111/​j.​1365-2591.​2009.​01544.​x PubMedCrossRef
Metadaten
Titel
Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid
verfasst von
Fernanda Gonçalves. Basso
Ana Paula Silveira. Turrioni
Diana Gabiela Soares
Vanderlei Salvador Bagnato
Josimeri Hebling
Carlos Alberto de Souza Costa
Publikationsdatum
01.10.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2267-3

Weitere Artikel der Ausgabe 10/2014

Supportive Care in Cancer 10/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.